Field Epidemiology Training Programme, Centre for Health Protection, Department of Health, Hong Kong, People's Republic of China.
Epidemiol Infect. 2012 May;140(5):814-7. doi: 10.1017/S0950268811001415. Epub 2011 Jul 29.
During the early phase of the influenza pandemic in 2009, all cases of laboratory-confirmed pandemic (H1N1) 2009 (pH1N1) infection required compulsory isolation in hospital. These cases were offered oseltamivir treatment and only allowed to be discharged from the hospital when three consecutive respiratory specimens were negative for the virus by reverse transcription-polymerase chain reaction (RT-PCR). We reviewed the case records of these patients to assess the viral shedding kinetics of the pH1N1 virus. We defined viral shedding duration as the interval from illness onset date to the date of collection of the last positive specimen from the patients. Fifty-six patients were included in the study, of whom 96% received oseltamivir. The median viral shedding duration of pH1N1 virus by viral culture and RT-PCR were 3 days and 4 days, respectively. Patients who started oseltamivir treatment >48 h after onset had a significantly longer median viral shedding duration by viral culture than those who started treatment within 48 h of onset (4 days vs. 2 days, P=0·014).
在 2009 年流感大流行的早期阶段,所有实验室确诊的大流行(H1N1)2009(pH1N1)感染病例均需强制住院隔离。这些病例都接受了奥司他韦治疗,只有当连续三次呼吸道标本通过逆转录-聚合酶链反应(RT-PCR)检测到病毒呈阴性时,才允许从医院出院。我们回顾了这些患者的病例记录,以评估 pH1N1 病毒的病毒脱落动力学。我们将病毒脱落持续时间定义为从发病日期到患者最后一次采集阳性标本的日期的间隔。本研究共纳入 56 例患者,其中 96%接受了奥司他韦治疗。病毒培养和 RT-PCR 检测 pH1N1 病毒的中位病毒脱落持续时间分别为 3 天和 4 天。发病后超过 48 小时开始奥司他韦治疗的患者,其病毒培养的中位病毒脱落持续时间明显长于发病后 48 小时内开始治疗的患者(4 天 vs. 2 天,P=0·014)。